AAMs Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track @accessiblemeds
AAMs Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track  @accessiblemeds
Uploaded September 2019 | Updated November 2026, 1 day ago
Karin Hessler, Assistant General Counsel at the Association for Accessible Medicines, urges attendees to add their voice to the discussion at the one essential generic and biosimilar conference of the year: GRx+Biosims 2019, November 4—6 in Bethesda, MD.

The conference legal track:
• explores drug pricing in the States;
• tracks the changing landscape of patents;
• analyses the challenges facing biosimilars; and
• takes a deep dive into U.S. trade policy.

For legal professionals in the generic and biosimilars industry, this is a perfect opportunity for attendees to receive CLE accreditations through our interactive breakout sessions.

This is one meeting you cannot afford to miss.

Learn more at grxbiosims.org/.
AAMs Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal TrackGeneric Drug Savings in the U.S.Mark Hendrickson: Experts, Regulators and Expo at GRx+BiosimsA Conference You Dont Want to Miss — GRx+Biosims 2018Biosimilars Council   Leading on Biosimilars for Americas PatientsSeniors Paying Billions More Than They Should — #DoesntAddUpGeneric Medicines 35th Birthday CelebrationGRx+Biosims 2020 ExpoJoin us at Access! 2026Access! 2019 Day 1 RecapInter Partes Review Process (IPR) - Explainer VideoThe CREATES Act - A Conservative, Market-based Solution to Lower Drug Prices
Association for Accessible Medicines |

AAM's Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER